DAMGO TFA
CAS No. ——
DAMGO TFA ( —— )
Catalog No. M17705 CAS No. ——
Potent, selective agonist of Mu-opioid receptor. Antinociceptive. Stimulates calcium-activated adenylyl cyclases related cAMP production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 170 | Get Quote |
|
| 10MG | 294 | Get Quote |
|
| 25MG | 557 | Get Quote |
|
| 50MG | 799 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDAMGO TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionPotent, selective agonist of Mu-opioid receptor. Antinociceptive. Stimulates calcium-activated adenylyl cyclases related cAMP production.
-
DescriptionPotent, selective agonist of Mu-opioid receptor. Antinociceptive. Stimulates calcium-activated adenylyl cyclases related cAMP production. Expresses chemokines and chemokine receptors through TGF-beta1. Increases food intake of rats.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorμ-opioid receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight627.6
-
Molecular FormulaC28H36F3N5O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOc2ccc(C[C@H](N)C(=O)N[C@H](C)C(=O)NCC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCO)cc2.FC(F)(F)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Onogi T,etal.DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops.FEBS Lett. 1995 Jan 2;357(1):93-7.
molnova catalog
related products
-
Naringenin-7-O-beta-...
Naringenin-7-O-beta-D-glucuronide is a natural product.
-
2,6-Dimethoxybenzoic...
2, 6-Dimethoxybenzoic acid is an active biochemical.
-
Grandifloroside
Grandifloroside shows good antioxidative and potent anti-inflammatory activities, it also exhibits potent inhibitory activity against TNF-α and 5α-reductase, suggests that it might be developed as a source of potent anti-oxidative and anti-inflammatory agents and therapeutic agent for benign prostatic hypertrophy (BPH).
Cart
sales@molnova.com